medigraphic.com
ENGLISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2014, Número 3

<< Anterior Siguiente >>

Ann Hepatol 2014; 13 (3)


Comparison of two diagnostic algorithms for the identification of patients with HCV viremia using a new HCV Antigen test

Reyes-Méndez MÁ, Juárez-Figueroa L, Iracheta-Hernández P, Medina-Islas Y, Ruiz-González V
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 11
Paginas: 337-342
Archivo PDF: 93.71 Kb.


PALABRAS CLAVE

Sin palabras Clave

RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. World Health Organization. Hepatitis C: Fact Sheet No. 164. World Health Organization 2011. Available at: http:// www.who.int/mediacentre/factsheets/fs164/en/ index.html

  2. Kershenobich D, Razavi HA, Sánchez-Avila JF, Bessone F, Coelho HS, Dagher L, Gonçales FL, et al. Trends and Projections of Hepatitis C epidemiology in Latin America. Liver International 2011; 31: S18-S29.

  3. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of non A non B hepatitis. Science 1989; 244: 362-4.

  4. Cornish N. Laboratory diagnosis and evaluation of treatment for HCV. College of American Pathologists. CAP Today 2005; 78.

  5. Albeldawi M, Ruiz-Rodriguez E, Carey WD. Hepatitis C virus, prevention, screening and interpretation of assays. Cleve Clin J Med 2010; 77: 616-26.

  6. Hosseini-Moghaddam SM, Iran-Pour E, Rotstein C, Husain S, Lilly L, Renner E, Mazulli T. Heptitis C core antigen and its clinical applicability: Potential advantages and disadvantages for diagnosis and follow up. Rev Med Virol 2012; 22: 156-65.

  7. Medici MC, Furlini G, Rodella A, Fuentes A, Monachetti A, Calderaro A, Galli S, et al. Hepatitis C virus core antigen: analytical performance, correlation with viremia and potential applications of a quantitative automated assay. J Clin Virol 2011; 51: 264-9.

  8. Ghany MG, Strader DB, Thomas DL, Seef LB, American Association for the Study of Liver Diseases. Diagnosis, management and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-74.

  9. Alter MJ, Kuhnert WL, Finelli L. Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus. Morbidity and Mortality Weekly Report 2003; 52; 1-16.

  10. Contreras AM, Ochoa-Jiménez RJ, Celis A, Méndez C, Olivares L, Rebolledo CE, Hernandez-Lugo I, et al. High Antibody level: an accurate serologic marker of viremia in asymptomatic people with hepatitis C infection. Transfusion 2010; 50: 1335-43. Doi: 10.1111/j.1537-2995.2009. 02571.x.

  11. Mederacke I, Wedemeyer H, Ciesek S, Steinmann E, Raupach R, Wursthorn K, Manns MP, et al. Performance and Clinical utility of a novel fully automated quantitative HCV-core antigen assay. J Clin Virol 2009; 46:210-5.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2014;13

ARTíCULOS SIMILARES

CARGANDO ...